Yin M - Search Results

1

Use of Plasma Metabolomics to Identify Diagnostic Biomarkers for Early Stage Epithelial Ovarian Cancer.

Fan L, Yin M, Ke C, Ge T, Zhang G, Zhang W, Zhou X, Lou G, Li K. Fan L, et al. Among authors: yin m. J Cancer. 2016 Jun 23;7(10):1265-72. doi: 10.7150/jca.15074. eCollection 2016. J Cancer. 2016. PMID: 27390602 Free PMC article.

2

Identification of metabolic biomarkers to diagnose epithelial ovarian cancer using a UPLC/QTOF/MS platform.

Fan L, Zhang W, Yin M, Zhang T, Wu X, Zhang H, Sun M, Li Z, Hou Y, Zhou X, Lou G, Li K. Fan L, et al. Among authors: yin m. Acta Oncol. 2012 Apr;51(4):473-9. doi: 10.3109/0284186X.2011.648338. Epub 2012 Jan 27. Acta Oncol. 2012. PMID: 22283470

3

Identification of potential biomarkers for ovarian cancer by urinary metabolomic profiling.

Zhang T, Wu X, Ke C, Yin M, Li Z, Fan L, Zhang W, Zhang H, Zhao F, Zhou X, Lou G, Li K. Zhang T, et al. Among authors: yin m. J Proteome Res. 2013 Jan 4;12(1):505-12. doi: 10.1021/pr3009572. Epub 2012 Dec 3. J Proteome Res. 2013. PMID: 23163809

4

LAPTM4B overexpression is a novel predictor of epithelial ovarian carcinoma metastasis.

Yin M, Xu Y, Lou G, Hou Y, Meng F, Zhang H, Li C, Zhou R. Yin M, et al. Int J Cancer. 2011 Aug 1;129(3):629-35. doi: 10.1002/ijc.25689. Epub 2010 Nov 28. Int J Cancer. 2011. PMID: 20857494

5

Identification of phosphatidylcholine and lysophosphatidylcholine as novel biomarkers for cervical cancers in a prospective cohort study.

Yin MZ, Tan S, Li X, Hou Y, Cao G, Li K, Kou J, Lou G. Yin MZ, et al. Tumour Biol. 2016 Apr;37(4):5485-92. doi: 10.1007/s13277-015-4164-x. Epub 2015 Nov 13. Tumour Biol. 2016. PMID: 26566624

6

Correlation of LAPTM4B polymorphisms with cervical carcinoma.

Meng F, Song H, Luo C, Yin M, Xu Y, Liu H, Zhou R, Lou G. Meng F, et al. Among authors: yin m. Cancer. 2011 Jun 15;117(12):2652-8. doi: 10.1002/cncr.25833. Epub 2011 Jan 10. Cancer. 2011. PMID: 21656743 Free article.

7

LAPTM4B overexpression is a novel independent prognostic marker for metastatic ovarian tumors.

Yin M, Lou C, Zhang W, Meng F, Zhang H, Ning X, Zhou R, Dong X, Lou G. Yin M, et al. Int J Gynecol Cancer. 2012 Jan;22(1):54-62. doi: 10.1097/IGC.0b013e318234f9ac. Int J Gynecol Cancer. 2012. PMID: 22193644

8

Discrimination between malignant and benign ovarian tumors by plasma metabolomic profiling using ultra performance liquid chromatography/mass spectrometry.

Zhang T, Wu X, Yin M, Fan L, Zhang H, Zhao F, Zhang W, Ke C, Zhang G, Hou Y, Zhou X, Lou G, Li K. Zhang T, et al. Among authors: yin m. Clin Chim Acta. 2012 May 18;413(9-10):861-8. doi: 10.1016/j.cca.2012.01.026. Epub 2012 Jan 30. Clin Chim Acta. 2012. PMID: 22309680

9

A metabolomics approach for predicting the response to neoadjuvant chemotherapy in cervical cancer patients.

Hou Y, Yin M, Sun F, Zhang T, Zhou X, Li H, Zheng J, Chen X, Li C, Ning X, Lou G, Li K. Hou Y, et al. Among authors: yin m. Mol Biosyst. 2014 Aug;10(8):2126-33. doi: 10.1039/c4mb00054d. Mol Biosyst. 2014. PMID: 24865370

10

MicroRNA-302b suppresses human epithelial ovarian cancer cell growth by targeting RUNX1.

Ge T, Yin M, Yang M, Liu T, Lou G. Ge T, et al. Among authors: yin m. Cell Physiol Biochem. 2014;34(6):2209-20. doi: 10.1159/000369664. Epub 2014 Dec 4. Cell Physiol Biochem. 2014. PMID: 25562167 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,997 results

Search Page

Filters